“Authorized” Generic Could Be Added To Brand’s “Best Price,” HHS Clarifies
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS assures Sen. Schumer (D-N.Y.) that administrative revision of “best price” reporting requirements is possible, provided the Centers for Medicare & Medicaid Services follows formal rulemaking procedures.